We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCYC
151
Bicycle Therapeutics
BCYC
$275M
$22.1M 0.14%
889,258
+20,000
+2% +$425K
HAL icon
152
Halliburton
HAL
$26.1B
$22M 0.14%
557,462
+147,034
+36% +$5.27M
MTD icon
153
Mettler-Toledo International
MTD
$28.1B
$21.8M 0.14%
16,385
-3,640
-18% -$4.49M
DAR icon
154
Darling Ingredients
DAR
$9.28B
$21.7M 0.14%
466,458
-266,281
-36% -$11.7M
ZBRA icon
155
Zebra Technologies
ZBRA
$13.5B
$21.6M 0.14%
71,731
+5,414
+8% +$1.45M
CME icon
156
CME Group
CME
$93.5B
$21.4M 0.14%
99,608
-18,744
-16% -$3.94M
CL icon
157
Colgate-Palmolive
CL
$74.2B
$21.3M 0.14%
236,860
+2,883
+1% +$244K
NUVL
158
DELISTED
Nuvalent
NUVL
$21.3M 0.14%
284,009
+4,000
+1% +$318K
CCK icon
159
Crown Holdings
CCK
$13.2B
$21.2M 0.14%
267,282
-964
-0.4% -$78.9K
NTRA icon
160
Natera
NTRA
$36.1B
$20.9M 0.13%
228,008
-13,979
-6% -$1.05M
SWK icon
161
Stanley Black & Decker
SWK
$14.6B
$20.8M 0.13%
212,003
+199,040
+1,535% +$18.3M
BLD
162
DELISTED
TopBuild
BLD
$20.7M 0.13%
47,047
-404
-0.9% -$158K
BIO icon
163
Bio-Rad Laboratories Class A
BIO
$8.86B
$20.6M 0.13%
59,658
-39,666
-40% -$13M
ICE icon
164
Intercontinental Exchange
ICE
$86.4B
$20.4M 0.13%
148,555
+15,692
+12% +$2.08M
PWR icon
165
Quanta Services
PWR
$88.3B
$20.4M 0.13%
78,448
+9,390
+14% +$2.08M
WAB icon
166
Wabtec
WAB
$51.7B
$20M 0.13%
137,549
-117
-0.1% -$15.8K
VRSK icon
167
Verisk Analytics
VRSK
$27.8B
$19.7M 0.13%
83,718
+59,046
+239% +$14.2M
MTZ icon
168
MasTec
MTZ
$24.7B
$19.7M 0.13%
211,341
+12,319
+6% +$937K
SRPT icon
169
Sarepta Therapeutics
SRPT
$1.63B
$19.5M 0.13%
151,000
-31,445
-17% -$3.85M
VLTO icon
170
Veralto
VLTO
$24.2B
$19.4M 0.12%
218,669
+64,487
+42% +$5.35M
DYN icon
171
Dyne Therapeutics
DYN
$4.28B
$19.2M 0.12%
675,624
-88,000
-12% -$1.99M
ARVN icon
172
Arvinas
ARVN
$529M
$19.1M 0.12%
462,554
-25,001
-5% -$1.09M
BR icon
173
Broadridge
BR
$18.3B
$19M 0.12%
92,757
+82,772
+829% +$16.7M
GE icon
174
GE Aerospace
GE
$377B
$19M 0.12%
135,496
+5,307
+4% +$625K
RVMD icon
175
Revolution Medicines
RVMD
$39.1B
$18.8M 0.12%
583,950
-23,000
-4% -$682K
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.